NCT02174900View on ClinicalTrials.gov

Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Malaria

Interventions

DRUG

Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine

DRUG

Artemether-Lumefantrine (AL) combination

DRUG

Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine

Trial Locations (1)

Unknown

Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou

All Listed Sponsors

collaborator

Centre national de recherche et de formation sur le paludisme

OTHER_GOV

collaborator

University Medical Center Nijmegen

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02174900 - Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM) | Biotech Hunter | Biotech Hunter